LCM
ONC icon

Laurion Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Laurion Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,200
Closed -$1.01M – 1229
2020
Q1 		$1.01M Sell
8,200
-2,600
-24% -$407K 0.01% 476
2019
Q4 		$1.79M Buy
+10,800
New +$1.79M 0.01% 477
2017
Q1 		– Sell
-19,462
Closed -$591K – 1610
2016
Q4 		$591K Buy
+19,462
New +$612K 0.01% 807

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Laurion Capital Management's ONC Position: Q2 2020 in Review

Laurion Capital Management sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 8,200 shares — an estimated $1.01M sold.

Laurion Capital Management first reported a position in ONC in Q4 2016 and held it in 3 quarters. The position peaked at $1.79M in Q4 2019. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

  • Laurion Capital Management reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
  • Laurion Capital Management sold 8,200 BeOne Medicines Ltd shares in Q2 2020, an estimated $1.01M.
  • Laurion Capital Management first reported a position in BeOne Medicines Ltd in Q4 2016 and held it in 3 quarters.
  • Laurion Capital Management's BeOne Medicines Ltd position peaked at $1.79M in Q4 2019.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Laurion Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.